Clinical Trials Logo

Erectile Dysfunction clinical trials

View clinical trials related to Erectile Dysfunction.

Filter by:

NCT ID: NCT06324006 Recruiting - Clinical trials for Erectile Dysfunction

A Phase 1 Trial of LIB-01 in Healthy Participants.

Start date: August 25, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to learn about the safety, tolerability and pharmacokinetics of LIB-01 in healthy male participants. The main questions it aims to answer are: - How safe and tolerable is LIB-01 when given once or repeatedly at different dose levels. - What are the pharmacokinetic characteristics of LIB-01 Participants will receive LIB-01 and be followed up for safety and pharmacokinetics by: - Adverse events - ECG - Blood sampling for laboratory parameters and pharmacokinetic analysis

NCT ID: NCT06301854 Not yet recruiting - Clinical trials for Erectile Dysfunction

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Start date: March 1, 2024
Phase: Phase 3
Study type: Interventional

This is a multicenter, open study to evaluate the long-term safety and efficacy of TPN171H in men with erectile dysfunction.

NCT ID: NCT06299332 Recruiting - Clinical trials for Erectile Dysfunction

Safety and Efficacy of Bi-Polar Radiofrequency for the Treatment of Erectile Dysfunction

Start date: June 23, 2023
Phase: N/A
Study type: Interventional

The goal of this prospective pilot study is to learn about the Safety and Efficacy of Radiofrequency (RF) for the Treatment of Erectile Dysfunction. This research study is trying to determine if RF therapy is safe and effective in patients with symptoms of erectile dysfunction (ED).

NCT ID: NCT06273592 Not yet recruiting - Clinical trials for Erectile Dysfunction

The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.

Erection 2
Start date: April 2024
Phase: N/A
Study type: Interventional

The goal of this study is to determine whether erectile function is differentially impacted by a single plant-based meat meal versus a single animal meat meal in healthy men with normal erectile function.

NCT ID: NCT06264635 Not yet recruiting - Clinical trials for Erectile Dysfunction

Evaluating the Efficacy of Platelet-Rich-Plasma (PRP) for Erectile Dysfunction

Start date: March 2024
Phase: Phase 1
Study type: Interventional

There is great interest in restorative therapies (platelet-rich plasma (PRP) injections, shockwave therapy and stem cell therapy) for ED given their non-invasive nature. However, data is still limited and requires further research prior to widespread adoption. Unfortunately, therapies such as PRP injections are being widely used without clinical evidence demonstrating its safety or effectiveness for the treatment of erectile dysfunction. 2-7 To date, there are no treatments that address the underlying cause of endothelial dysfunction, although low-intensity shockwave therapy for ED has shown promising results. Platelet-derived therapies targeting inflammation and promoting tissue/nerve regeneration and may represent a potential treatment option towards this direction. The investigators propose to perform Canada's first pilot RCT to evaluate and safety and efficacy of PRP for the treatment of ED.

NCT ID: NCT06264414 Not yet recruiting - Clinical trials for Erectile Dysfunction

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

AUSTRÁLIA
Start date: February 2025
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia

NCT ID: NCT06220968 Not yet recruiting - Clinical trials for Erectile Dysfunction With Diabetes Mellitus

Impact of Glycemic Control on Penile Duplex Results

Start date: March 2024
Phase:
Study type: Observational [Patient Registry]

The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.

NCT ID: NCT06219785 Recruiting - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

Low-intensity Shockwave Therapy for Post-radical Prostatectomy Erectile Dysfunction

Start date: January 10, 2024
Phase: N/A
Study type: Interventional

This research study is trying to determine if Low-Intensity shock wave therapy (LiSWT) is safe and effective in patients with symptoms of erectile dysfunction (ED) after radical prostatectomy.

NCT ID: NCT06213077 Recruiting - Clinical trials for Erectile Dysfunction

The Effects of a Nitrate Supplementation on Erectile Function

Start date: December 12, 2023
Phase: N/A
Study type: Interventional

Twenty (20) individuals to be recruited from Ballantyne Medical Associates in Charlotte, NC, without any significant chronic medical history. These patients are general patients for primary care that meet inclusion criteria. Patients will be screened and enrolled by Dr. Bauer and his delegated research staff upon patient consult. Patients will be informed of the purpose of the study including risks, benefits, and alternative treatments to the study. After the potential participants have been given the opportunity to ask questions and have their questions answered, they will be asked to sign an informed consent prior to any study-specific procedures being performed. Blinded test product will be randomly assigned to study subjects. Test group 1 will be dosed with a placebo capsule taken two capsules once daily Test group 2 will be dosed with Berkeley Life capsules taken two capsules once daily. At baseline, prior to crossover to the other treatment, and at the study's conclusion, NO levels will be monitored using salivary nitric oxide test strips. Both test groups will remain on their existing treatment protocol throughout the study.

NCT ID: NCT06200987 Recruiting - Incontinence Clinical Trials

Penile Vibratory Stimulation in the Prevention of Sexual Dysfunction and Urinary Incontinence After Radical Prostatectomy

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

To investigate if post-operative penile vibration stimulation kan be used to reduce or prevent sexual dysfunction and urinary incontinence after radical prostatectomy. This will be done in a randomized, controlled, non-blinded study. Men that undergo nerve preserving surgery for prostate cancer is allocated into an intervention group and a control group. A total of 100 men will be included for a power of 80%. The intervention group will be instructed to use the "Ferticare 2.0" vibrator for at least five minutes a day with an amplitude of 1 mm and frequency of 90 Hz (these settings were found in a pilot study) for a total of 9 months. Both groups will do the standard pelvic floor training program and both groups will be offered regular phosphodiesterase-5-inhibitor treatment. Before surgery, 3, 6 and 10 months after the patients will have to fill out four different questionnaires regarding sexual and urinary function, including IIEF-EF, EHS, "neglected side effects" and ICIQ-SF. (10 months is due to a wash-out period of 1 month after the intervention). The collected data will be analysed and the primary goal is to see if there is a significant difference in average spontaneous IIEF-EF score in the two groups 10 months after the surgery.